首页> 外文期刊>Bulletin of experimental biology and medicine >Analysis of Mechanisms of Interaction between Ciprofloxacin-Based Radiopharmaceutical Labeled with Technetium-99m and Cultured Staphylococcus aureus
【24h】

Analysis of Mechanisms of Interaction between Ciprofloxacin-Based Radiopharmaceutical Labeled with Technetium-99m and Cultured Staphylococcus aureus

机译:环丙沙星99m标记的环丙沙星放射性药物与培养的金黄色葡萄球菌相互作用的机理分析

获取原文
获取原文并翻译 | 示例
           

摘要

Mechanisms of interaction between ciprofloxacin-based radiopharmaceutical labeled with technetium-99m and cultured Staphylococcus aureus were studied. The substance, reagent for radiopharmaceutical, and the radiopharmaceutical demonstrated similar bactericidal activity against the test bacterial cultures, which confi rmed specifi c antibacterial activity of technetium-99m-labeled ciprofloxacin. The technetium-99m-labeled antibiotic reversibly interacts with inactivated Staphylococcus aureus culture, which indicates the existence of an additional non-specific pathway for radiopharmaceutical accumulation in the bacterial inflammation focus. Our experiment ruled out the possibility of binding free technetium-99m at concentrations < 5% (its concentration in the radiopharmaceutical) with Staphylococcus aureus.
机译:研究了tech99m标记的环丙沙星放射性药物与金黄色葡萄球菌相互作用的机理。该物质,放射性药物试剂和放射性药物对测试细菌培养物表现出相似的杀菌活性,证实了tech 99m标记的环丙沙星的特定抗菌活性。 m 99m标记的抗生素与灭活的金黄色葡萄球菌培养物可逆地相互作用,这表明在细菌炎症灶中存在放射性药物蓄积的其他非特异性途径。我们的实验排除了浓度小于5%(其在放射性药物中的浓度)与金黄色葡萄球菌结合的tech 99m的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号